John Finn insider trades: Trius Therapeutics (TSRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 22, 2013 | TSRX | ↓ Sell | 1,000 | $12.10 | $12K | By the John and Debbie Finn Trust | Jul 23, 2013 (1d) |
| Jul 15, 2013 | TSRX | ↓ Sell | 3,500 | $10.55 | $37K | By the John and Debbie Finn Trust | Jul 16, 2013 (1d) |
| Jul 12, 2013 | TSRX | ↓ Sell | 6,500 | $9.81 | $64K | By the John and Debbie Finn Trust | Jul 12, 2013 (0d) |
| Jun 12, 2013 | TSRX | ↓ Sell | 3,000 | $9.08 | $27K | By the John and Debbie Finn Trust | Jun 12, 2013 (0d) |
| Jun 11, 2013 | TSRX | ↓ Sell | 1,000 | $8.94 | $9K | By the John and Debbie Finn Trust | Jun 11, 2013 (0d) |
| May 14, 2013 | TSRX | ↓ Sell | 5,000 | $8.10 | $41K | Direct | May 16, 2013 (2d) |
| May 10, 2013 | TSRX | ↓ Sell | 3,000 | $7.47 | $22K | Direct | May 13, 2013 (3d) |
| Apr 24, 2013 | TSRX | ↓ Sell | 500 | $7.10 | $4K | By The John and Debbie Finn Trust | Apr 26, 2013 (2d) |
| Mar 15, 2013 | TSRX | ↓ Sell | 1,500 | $7.10 | $11K | By The John and Debbie Finn Trust | Mar 18, 2013 (3d) |
| Oct 11, 2011 | TSRX | ↓ Sell | 500 | $6.19 | $3K | By The John and Debbie Finn Trust | Oct 12, 2011 (1d) |
| Sep 15, 2011 | TSRX | ↓ Sell | 1,000 | $6.47 | $6K | By The John and Debbie Finn Trust | Sep 16, 2011 (1d) |
| Aug 12, 2011 | TSRX | ↓ Sell | 500 | $7.00 | $4K | By The John and Debbie Finn Trust | Aug 12, 2011 (0d) |
| Aug 9, 2011 | TSRX | ↓ Sell | 1,000 | $5.96 | $6K | By The John and Debbie Finn Trust | Aug 10, 2011 (1d) |
| Jul 20, 2011 | TSRX | ↓ Sell | 500 | $8.00 | $4K | By The John and Debbie Finn Trust | Jul 21, 2011 (1d) |
| Jul 12, 2011 | TSRX | ↓ Sell | 1,500 | $7.23 | $11K | By The John and Debbie Finn Trust | Jul 13, 2011 (1d) |
| Jun 9, 2011 | TSRX | ↓ Sell | 2,000 | $8.09 | $16K | By The John and Debbie Finn Trust | Jun 10, 2011 (1d) |
| May 16, 2011 | TSRX | ↓ Sell | 7,000 | $8.02 | $56K | By The John and Debbie Finn Trust | May 17, 2011 (1d) |
| May 12, 2011 | TSRX | ↓ Sell | 1,500 | $7.00 | $11K | By The John and Debbie Finn Trust | May 13, 2011 (1d) |
| May 10, 2011 | TSRX | ↓ Sell | 1,000 | $6.02 | $6K | By The John and Debbie Finn Trust | May 10, 2011 (0d) |
| May 3, 2011 | TSRX | ↓ Sell | 800 | $6.00 | $5K | By The John and Debbie Finn Trust | May 4, 2011 (1d) |
| Apr 11, 2011 | TSRX | ↓ Sell | 500 | $5.36 | $3K | By The John and Debbie Finn Trust | Apr 12, 2011 (1d) |
| Mar 30, 2011 | TSRX | ↓ Sell | 200 | $6.00 | $1K | By The John and Debbie Finn Trust | Mar 31, 2011 (1d) |
| Mar 9, 2011 | TSRX | ↓ Sell | 500 | $5.86 | $3K | By The John and Debbie Finn Trust | Mar 10, 2011 (1d) |
| Mar 1, 2011 | TSRX | ↓ Sell | 500 | $7.00 | $4K | By The John and Debbie Finn Trust | Mar 3, 2011 (2d) |
| Feb 18, 2011 | TSRX | ↓ Sell | 1,000 | $5.50 | $6K | By The John and Debbie Finn Trust | Feb 22, 2011 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John Finn's insider trades
John Finn is Chief Scientific Officer at Trius Therapeutics (TSRX). Since Feb 18, 2011, John has reported no open-market purchases and 25 sales worth $369K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TSRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.